ATE412903T1 - Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten - Google Patents
Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheitenInfo
- Publication number
- ATE412903T1 ATE412903T1 AT04717062T AT04717062T ATE412903T1 AT E412903 T1 ATE412903 T1 AT E412903T1 AT 04717062 T AT04717062 T AT 04717062T AT 04717062 T AT04717062 T AT 04717062T AT E412903 T1 ATE412903 T1 AT E412903T1
- Authority
- AT
- Austria
- Prior art keywords
- disorders
- diseases
- diagnostics
- receptor
- related diseases
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 208000019423 liver disease Diseases 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000014001 urinary system disease Diseases 0.000 abstract 2
- 101150009981 C5AR1 gene Proteins 0.000 abstract 1
- 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 abstract 1
- 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000056190 human C5AR1 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03005467 | 2003-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412903T1 true ATE412903T1 (de) | 2008-11-15 |
Family
ID=33016821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04717062T ATE412903T1 (de) | 2003-03-17 | 2004-03-04 | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060240436A1 (de) |
| EP (1) | EP1606621B1 (de) |
| AT (1) | ATE412903T1 (de) |
| DE (1) | DE602004017439D1 (de) |
| ES (1) | ES2314383T3 (de) |
| WO (1) | WO2004082568A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1654545A2 (de) * | 2003-08-08 | 2006-05-10 | Genova Ltd. | Mit herzkreislaufstörungen im zusammenhang stehende sezernierte polypeptidspezies |
| ES2364335T3 (es) * | 2003-12-24 | 2011-08-31 | G2 Inflammation Pty Ltd | Mamífero no humano transgénico que comprende un polinucleótido que codifica el c5ar humano o humanizado. |
| PL2718322T3 (pl) | 2011-06-06 | 2019-07-31 | Novo Nordisk A/S | Lecznicze przeciwciała |
| US20180243370A1 (en) * | 2015-09-14 | 2018-08-30 | Children's Hospital Medical Center | Methods and compositions for treatment of gaucher disease via modulation of c5a receptor |
| TWI869528B (zh) | 2020-01-13 | 2025-01-11 | 美商威特拉公司 | C5ar1抗體分子及其用途 |
| CN120309734A (zh) | 2021-01-13 | 2025-07-15 | 威特拉公司 | 人源化补体5a受体1抗体和其使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614370A (en) * | 1994-03-18 | 1997-03-25 | Merck & Co., Inc. | Assay to identify human C5a antagonists and agonists |
| US5861272A (en) * | 1995-06-02 | 1999-01-19 | Human Genome Sciences, Inc. | C5A receptor |
| WO2002022556A1 (en) * | 2000-09-14 | 2002-03-21 | Mitsubishi Pharma Corporation | Novel amide derivatives and medicinal use thereof ugs |
-
2004
- 2004-03-04 WO PCT/EP2004/002175 patent/WO2004082568A2/en not_active Ceased
- 2004-03-04 ES ES04717062T patent/ES2314383T3/es not_active Expired - Lifetime
- 2004-03-04 EP EP04717062A patent/EP1606621B1/de not_active Expired - Lifetime
- 2004-03-04 AT AT04717062T patent/ATE412903T1/de not_active IP Right Cessation
- 2004-03-04 DE DE602004017439T patent/DE602004017439D1/de not_active Expired - Lifetime
- 2004-03-04 US US10/548,962 patent/US20060240436A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2314383T3 (es) | 2009-03-16 |
| WO2004082568A3 (en) | 2005-01-13 |
| DE602004017439D1 (de) | 2008-12-11 |
| US20060240436A1 (en) | 2006-10-26 |
| WO2004082568A2 (en) | 2004-09-30 |
| EP1606621A2 (de) | 2005-12-21 |
| EP1606621B1 (de) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| EP2017620A3 (de) | Diagnostika und Therapeutika für mit Dipeptidyl-peptidase 1 (DPP1) assoziierten Krankheiten | |
| DE602004017439D1 (de) | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten | |
| ATE552503T1 (de) | Ctgf als biomarker, therapeutisches und diagnostisches ziel | |
| WO2023166318A3 (en) | Therapeutic antibodies | |
| WO2005103702A3 (en) | Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2) | |
| WO2005078117A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6) | |
| ATE554393T1 (de) | Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen | |
| WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
| WO2004104574A3 (en) | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 7 (ccr7) | |
| DE602004014261D1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten | |
| WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
| DE602004013770D1 (de) | Diagnostik- und therapie- verfahren von mit pils verbundenen krankheiten | |
| ATE397751T1 (de) | Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheiten | |
| WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
| WO2005040822A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 25 (gpr25) | |
| WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
| WO2004106934A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) | |
| WO2005103711A3 (en) | Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1) | |
| WO2004104595A3 (en) | Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) | |
| WO2005106488A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) | |
| WO2005026719A3 (en) | Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3) | |
| WO2007141005A8 (en) | Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target | |
| WO2004097422A3 (en) | Diagnostics and therapeutics for diseases associated with calcitonin receptor (calcr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |